Tagged With Biotech

Fauci says 'it's going to be months' before a coronavirus vaccine is approved for children


6 crucial unanswered questions about AstraZeneca's coronavirus vaccine results


The vaccine breakthroughs at Moderna and Pfizer are the latest examples of how immigrants have been driving billions in American innovation for decades



Pfizer says its coronavirus vaccine is 95% effective as it gears up to ask the FDA to authorise the shot


The man in charge of evaluating coronavirus vaccines for the FDA lays out why it will take weeks to vet a COVID-19 shot


The CEO of Moderna says every American will likely have access to a COVID-19 vaccine by June



Moderna says its coronavirus vaccine is 94.5% effective against COVID-19, a crucial victory in the fight against the pandemic


20 million Americans could get a coronavirus vaccine next month, according to the head of Operation Warp Speed


French drugmaker Sanofi has just invested $59 million in biotech investor Jeito Capital to fund innovation in the biopharma pipeline


Five Prime Therapeutics soars 386% after positive cancer trial results


Biogen plummets 32% after its Alzheimer's therapy fails to win support from FDA advisory committee


The election's consequences for digital health



Moderna, BioNtech surge as COVID-19 vaccine development progresses amid virus spike


27 biotech execs who've sold the most stock


27 pharma execs involved in the hunt for COVID-19 vaccines and treatments have raked in more than $1 billion by selling stock this year. Here's who's cashed in the most.


Pfizer will start testing its coronavirus vaccine on children as young as 12, a crucial step to bringing the shot to more people



Trump's coronavirus vaccine czar envisions '3 waves' of coronavirus vaccine data and approvals. Here's how he sees the next 6 months playing out.


Trump's coronavirus vaccine czar is backing the FDA on safety standards that make a vaccine approval unlikely if not impossible before the election


Meet the 16 up-and-coming VC investors who are funding the future of healthcare in 2020


MyoKardia soars 59% after Bristol-Myers agrees to acquire it for $13 billion in cash